PVT501

N/A

Report date: 2025/10/31 18:01:21

Base Information

Drug NamePVT501
Drug Alias NamePVT-501
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesParvus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesParvus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A